<table id="table4" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 4: Population Pharmacokinetic Estimates of Etravirine 200 mg b.i.d. in HIV-1-Infected Subjects (Integrated Data from Phase 3 Trials at Week 48)<footnote>All HIV-1-infected subjects enrolled in Phase 3 clinical trials received darunavir/ritonavir 600/100 mg b.i.d. as part of their background regimen. Therefore, the pharmacokinetic parameter estimates shown in Table 4 account for reductions in the pharmacokinetic parameters of etravirine due to co-administration of INTELENCE<sup>®</sup> with darunavir/ritonavir.</footnote>
</caption>
<col align="left" valign="top" width="50%"></col>
<col align="center" valign="top" width="50%"></col>
<thead>
<tr>
<th align="center" stylecode="Lrule Rrule">Parameter</th>
<th stylecode="Rrule">Etravirine 200 mg b.i.d.<br/>N = 575</th>
</tr>
</thead>
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">AUC<sub>12h</sub> (ng∙h/mL)</td>
<td stylecode="Rrule"></td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">  Geometric Mean ± Standard Deviation</td>
<td stylecode="Rrule">4522 ± 4710</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">  Median (Range)</td>
<td stylecode="Rrule">4380 (458 - 59084)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">C<sub>0h</sub> (ng/mL)</td>
<td stylecode="Rrule"></td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">  Geometric Mean ± Standard Deviation</td>
<td stylecode="Rrule">297 ± 391</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">  Median (Range)</td>
<td stylecode="Rrule">298 (2 - 4852)</td>
</tr>
</tbody>
</table>